Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Rosen HR et al. |
Significance of early aminotransferase elevation after liver transplantation. |
1998 |
Transplantation |
pmid:9448146
|
McCune TR et al. |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. |
1998 |
Transplantation |
pmid:9448150
|
O'Grady J |
C(2) monitoring: out of the blocks but with some way to go! |
2004 |
Transplantation |
pmid:15201659
|
Frassetto LA et al. |
Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. |
2014 |
Transplantation |
pmid:24389906
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Fung JJ |
Tacrolimus and transplantation: a decade in review. |
2004 |
Transplantation |
pmid:15201685
|
Busuttil RW and Lake JR |
Role of tacrolimus in the evolution of liver transplantation. |
2004 |
Transplantation |
pmid:15201686
|
First MR |
Transplantation in the nineties. |
1992 |
Transplantation |
pmid:1370734
|
Vincenti F |
A decade of progress in kidney transplantation. |
2004 |
Transplantation |
pmid:15201687
|
Kee TY et al. |
Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. |
2006 |
Transplantation |
pmid:16861939
|
Pascual J et al. |
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. |
2006 |
Transplantation |
pmid:16861942
|
Bunnapradist S et al. |
Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids. |
2003 |
Transplantation |
pmid:12865780
|
Asberg A et al. |
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. |
2006 |
Transplantation |
pmid:16861943
|
Pfitzmann R et al. |
Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. |
2003 |
Transplantation |
pmid:12865798
|
Yamagami S et al. |
Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. |
1997 |
Transplantation |
pmid:9233699
|
Sawabe T et al. |
Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. |
1997 |
Transplantation |
pmid:9233725
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
Drachenberg CB et al. |
Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. |
1999 |
Transplantation |
pmid:10459544
|
van Hooff JP et al. |
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. |
2003 |
Transplantation |
pmid:12829890
|
Heffron TG et al. |
Pediatric liver transplantation with daclizumab induction. |
2003 |
Transplantation |
pmid:12829908
|
Gonwa T et al. |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. |
2003 |
Transplantation |
pmid:12829910
|
Stegall MD et al. |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9422416
|
Shihab FS et al. |
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. |
1997 |
Transplantation |
pmid:9422427
|
Vu MD et al. |
Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. |
1997 |
Transplantation |
pmid:9422432
|
Chaftari AM et al. |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. |
2012 |
Transplantation |
pmid:22814329
|
Kasahara M et al. |
Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. |
2001 |
Transplantation |
pmid:11211185
|
Oz HS et al. |
Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11685124
|
Staatz CE et al. |
Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. |
2001 |
Transplantation |
pmid:11579300
|
Selzner N et al. |
Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. |
2001 |
Transplantation |
pmid:11579301
|
Savoldo B et al. |
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients. |
2001 |
Transplantation |
pmid:11579304
|
Fisher NC et al. |
Chronic renal failure following liver transplantation: a retrospective analysis. |
1998 |
Transplantation |
pmid:9679823
|
Sanchez-Campos S et al. |
Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. |
1998 |
Transplantation |
pmid:9679826
|
Shao X et al. |
Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. |
2012 |
Transplantation |
pmid:23128973
|
Tsuchiya T et al. |
Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus. |
2013 |
Transplantation |
pmid:23792649
|
Newell KA et al. |
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. |
1997 |
Transplantation |
pmid:9381541
|
Iyengar AR et al. |
Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. |
1997 |
Transplantation |
pmid:9158008
|
Størset E et al. |
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. |
2015 |
Transplantation |
pmid:25886918
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
Takaya S et al. |
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. |
1992 |
Transplantation |
pmid:1279851
|
Shapiro R et al. |
Posttransplant diabetes in pediatric recipients on tacrolimus. |
1999 |
Transplantation |
pmid:10096540
|
Wasik M et al. |
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. |
1991 |
Transplantation |
pmid:1702910
|
Bronster DJ et al. |
Tacrolimus-associated mutism after orthotopic liver transplantation. |
2000 |
Transplantation |
pmid:11014653
|
Hilbrands R et al. |
Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. |
2013 |
Transplantation |
pmid:23857001
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Nashan B et al. |
Clinical validation studies of Neoral C(2) monitoring: a review. |
2002 |
Transplantation |
pmid:12023607
|
Mittal SK et al. |
Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. |
2009 |
Transplantation |
pmid:19667950
|
Kihm LP et al. |
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. |
2012 |
Transplantation |
pmid:22470107
|
Hoogtanders K et al. |
Dried blood spot measurement of tacrolimus is promising for patient monitoring. |
2007 |
Transplantation |
pmid:17264824
|
Ahuja M et al. |
Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. |
2001 |
Transplantation |
pmid:11349723
|
Pérgola PE et al. |
Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. |
2001 |
Transplantation |
pmid:11349738
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Ekberg H et al. |
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. |
2009 |
Transplantation |
pmid:19424036
|
Mestres J et al. |
Late subcapsular lymphocele in a kidney graft. |
2012 |
Transplantation |
pmid:22487814
|
Cherikh WS et al. |
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. |
2003 |
Transplantation |
pmid:14627905
|
Neumann UP et al. |
Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. |
2001 |
Transplantation |
pmid:11374419
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Rajesh KG et al. |
Mitochondrial permeability transition-pore inhibition enhances functional recovery after long-time hypothermic heart preservation. |
2003 |
Transplantation |
pmid:14627909
|
Sato T et al. |
Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. |
2003 |
Transplantation |
pmid:14627910
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. |
2008 |
Transplantation |
pmid:18622280
|
Vignali D et al. |
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. |
2016 |
Transplantation |
pmid:27306531
|
Homma M et al. |
Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation. |
2002 |
Transplantation |
pmid:11821750
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
2000 |
Transplantation |
pmid:11003353
|
Arroyo Hornero R et al. |
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. |
2017 |
Transplantation |
pmid:28118317
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Inoue T et al. |
Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. |
2000 |
Transplantation |
pmid:11003356
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Tan HP et al. |
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. |
2008 |
Transplantation |
pmid:19104412
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Nankivell BJ et al. |
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. |
2016 |
Transplantation |
pmid:27306529
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Blakolmer K et al. |
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. |
2000 |
Transplantation |
pmid:10868635
|
Neuhaus P et al. |
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial. |
2000 |
Transplantation |
pmid:10868638
|
Verleden GM et al. |
Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. |
2002 |
Transplantation |
pmid:12131703
|
Johnson C et al. |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. |
2000 |
Transplantation |
pmid:10755536
|
Ekser B et al. |
Hepatic function after genetically engineered pig liver transplantation in baboons. |
2010 |
Transplantation |
pmid:20606605
|
Ochiai T et al. |
Studies of the effects of FK506 on renal allografting in the beagle dog. |
1987 |
Transplantation |
pmid:2447688
|
Miller J et al. |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
2000 |
Transplantation |
pmid:10755543
|
De Ruvo N et al. |
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. |
2005 |
Transplantation |
pmid:16003226
|
Mohamed MA et al. |
TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus. |
2000 |
Transplantation |
pmid:10755567
|
Reich DJ et al. |
Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. |
2005 |
Transplantation |
pmid:16003228
|
Guasch A et al. |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. |
2010 |
Transplantation |
pmid:20811320
|
Alloway R et al. |
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. |
2007 |
Transplantation |
pmid:17589351
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. |
2004 |
Transplantation |
pmid:14742989
|
Wennberg L et al. |
Preapheresis immunosuppressive induction: necessary or harmful? |
2007 |
Transplantation |
pmid:18162987
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
Azzola A et al. |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. |
2004 |
Transplantation |
pmid:14742993
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Hoerning A et al. |
Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. |
2015 |
Transplantation |
pmid:25099702
|
Ricordi C et al. |
In vivo effect of FK506 on human pancreatic islets. |
1991 |
Transplantation |
pmid:1716797
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Yilmaz MI et al. |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. |
2005 |
Transplantation |
pmid:16378057
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|